ATE191642T1 - Herstellung von proteinmikrospähren, filmen und beschichtungen - Google Patents

Herstellung von proteinmikrospähren, filmen und beschichtungen

Info

Publication number: ATE191642T1
Authority: AT; Austria
Prior art keywords: coatings; protein; film; production; alpha
Prior art date: 1994-10-10

Application number

AT95933520T

Other languages

English (en)

Inventor

Allan Gerald Arthur Coombes

Wu Lin

Derek Thomas O'hagen

Stanley Stewart Davis

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-10

Filing date

1995-10-10

Publication date

2000-04-15

1995-10-10 Application filed by Chiron Corp filed Critical Chiron Corp

2000-04-15 Application granted granted Critical

2000-04-15 Publication of ATE191642T1 publication Critical patent/ATE191642T1/de

Links

239000004005 microsphere Substances 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
229940061720 alpha hydroxy acid Drugs 0.000 abstract 2
150000001280 alpha hydroxy acids Chemical class 0.000 abstract 2
239000007864 aqueous solution Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 abstract 1
235000014655 lactic acid Nutrition 0.000 abstract 1
239000004310 lactic acid Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
102000035118 modified proteins Human genes 0.000 abstract 1
108091005573 modified proteins Proteins 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
- Y10S977/779—Possessing nanosized particles, powders, flakes, or clusters other than simple atomic impurity doping
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/827—Nanostructure formed from hybrid organic/inorganic semiconductor compositions
- Y10S977/829—Organic or biological core coated with inorganic shell
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/827—Nanostructure formed from hybrid organic/inorganic semiconductor compositions
- Y10S977/83—Inorganic core or cluster coated with organic or biological shell
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/849—Manufacture, treatment, or detection of nanostructure with scanning probe
- Y10S977/855—Manufacture, treatment, or detection of nanostructure with scanning probe for manufacture of nanostructure
- Y10S977/857—Manufacture, treatment, or detection of nanostructure with scanning probe for manufacture of nanostructure including coating
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/89—Deposition of materials, e.g. coating, cvd, or ald
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/905—Specially adapted for travel through blood circulatory system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/918—Immunological
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Manufacturing Of Micro-Capsules (AREA)

AT95933520T 1994-10-10 1995-10-10 Herstellung von proteinmikrospähren, filmen und beschichtungen ATE191642T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9420355A GB9420355D0 (en)	1994-10-10	1994-10-10	Preparation of protein microspheres, films and coatings
PCT/GB1995/002393 WO1996010992A1 (en)	1994-10-10	1995-10-10	Preparation of protein microspheres, films and coatings

Publications (1)

Publication Number	Publication Date
ATE191642T1 true ATE191642T1 (de)	2000-04-15

Family

ID=10762585

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95933520T ATE191642T1 (de)	1994-10-10	1995-10-10	Herstellung von proteinmikrospähren, filmen und beschichtungen

Country Status (12)

Country	Link
US (2)	US6007791A (de)
EP (1)	EP0785776B1 (de)
JP (1)	JP3990447B2 (de)
AT (1)	ATE191642T1 (de)
AU (1)	AU3614895A (de)
DE (1)	DE69516296T2 (de)
DK (1)	DK0785776T3 (de)
ES (1)	ES2145298T3 (de)
GB (1)	GB9420355D0 (de)
GR (1)	GR3033210T3 (de)
PT (1)	PT785776E (de)
WO (1)	WO1996010992A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420355D0 (en) *	1994-10-10	1994-11-23	Univ Nottingham	Preparation of protein microspheres, films and coatings
IT1293087B1 (it) *	1997-07-10	1999-02-11	Isi Ist Sierovaccinogeno Ital	Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la
US5962018A (en) *	1998-04-28	1999-10-05	Avon Products, Inc.	Method of treating the skin with organic acids in anhydrous microsphere delivery systems
AUPQ326499A0 (en) *	1999-10-05	1999-10-28	Commonwealth Scientific And Industrial Research Organisation	Nanoparticle films
FR2810336B1 (fr) *	2000-06-19	2003-01-31	Prod Oenologiques J Laffort &	Procede de fabrication d'un produit de clarification ajustee d'un vin et produit de clarification obtenu
US7219837B2 (en)	2002-09-12	2007-05-22	Integrated Engineering B.V.	Identification system
US7731967B2 (en)	2003-04-30	2010-06-08	Novartis Vaccines And Diagnostics, Inc.	Compositions for inducing immune responses
US20050186183A1 (en) *	2003-12-08	2005-08-25	Deangelo Joseph	Stabilized products, processes and devices for preparing same
WO2005055945A2 (en) *	2003-12-08	2005-06-23	Gel-Del Technologies, Inc.	Mucoadhesive drug delivery devices and methods of making and using thereof
US20070190101A1 (en) *	2004-03-31	2007-08-16	Chunlin Yang	Flowable bone grafts
CA2586035A1 (en) *	2004-11-01	2006-05-11	Biosante Pharmaceuticals, Inc.	Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
US7964200B2 (en)	2005-05-18	2011-06-21	Children's Hospital & Research Center At Oakland	Methods and compositions for immunizing against Chlamydia infection
US7485609B2 (en) *	2005-09-29	2009-02-03	Kimberly-Clark Worldwide, Inc.	Encapsulated liquid cleanser
CA2645070C (en) *	2006-03-08	2014-02-04	Nihon Nohyaku Co., Ltd.	Pharmaceutical composition for external use
RU2419429C2 (ru)	2006-03-08	2011-05-27	Нихон Нохияку Ко.,Лтд.	Фармацевтическая композиция для наружного применения
EP1836897A1 (de) *	2006-03-22	2007-09-26	Nestec S.A.	Festes Produkt mit Öltröpfchen
DK2444807T3 (da) *	2006-11-01	2014-08-11	Ventana Med Syst Inc	Mono- og dinitropyrazolhaptenkonjugater
US7682789B2 (en) *	2007-05-04	2010-03-23	Ventana Medical Systems, Inc.	Method for quantifying biomolecules conjugated to a nanoparticle
EP2167963B1 (de)	2007-05-23	2019-04-17	Ventana Medical Systems, Inc.	Polymerträger für immunohistochemie und in situ hybridisierung
CN101808639B (zh) *	2007-09-05	2012-12-05	宝丽制药股份有限公司	抗真菌医药组合物
EP2191827B1 (de)	2007-09-05	2013-10-30	Pola Pharma Inc.	Antimykotische zusammensetzung
JP5529539B2 (ja) *	2007-09-05	2014-06-25	株式会社ポーラファルマ	医薬組成物
TW200922585A (en) *	2007-10-26	2009-06-01	Astrazeneca Ab	Amino 1,2,4-triazole derivatives as modulators of mGluR5
WO2009149013A2 (en)	2008-06-05	2009-12-10	Ventana Medical Systems, Inc.	Compositions comprising nanomaterials and method for using such compositions for histochemical processes
CA2739561C (en) *	2008-10-07	2017-03-28	University Of Pretoria	Process for producing protein microparticles
KR101409792B1 (ko)	2009-04-09	2014-06-19	니혼노야쿠가부시키가이샤	항진균성 약제학적 조성물
EP2416757A2 (de)	2009-04-09	2012-02-15	Pola Pharma Inc.	Antimykotische pharmazeutische zusammensetzung
WO2011024620A1 (en)	2009-08-25	2011-03-03	Pola Pharma Inc.	Antimycotic pharmaceutical composition
US9211283B2 (en) *	2009-12-11	2015-12-15	Biolitec Pharma Marketing Ltd	Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
USPP22463P3 (en) *	2010-02-16	2012-01-17	Menachem Bornstein	Gypsophila plant named ‘Pearl Blossom’
CN103026230B (zh) *	2010-07-23	2015-01-14	卢米耐克斯公司	共偶联以控制免疫测定中试剂的反应性
US11246915B2 (en)	2010-09-15	2022-02-15	Applied Molecular Transport Inc.	Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
RU2593715C2 (ru)	2010-09-15	2016-08-10	Рэндэлл Дж. МРСНИ	Системы и способы доставки биоактивных средств с применением транспортных последовательностей, происходящих от бактериального токсина
WO2013084207A1 (pt)	2011-12-07	2013-06-13	Universidade Do Minho	Formulações micelares proteicas e respectivo método de produção
EP2625966A1 (de)	2012-02-13	2013-08-14	Bionanoplus, S.L.	Nanopartikel mit einem pflanzlichen hydrophoben Protein und wassermischbare nichtflüchtige organische Lösung sowie Verwendungen davon
CN106470707A (zh)	2014-05-07	2017-03-01	应用分子运输有限责任公司	用于口服递送生物活性货物的cholix毒素衍生的融合分子
JP6444236B2 (ja) *	2015-03-27	2018-12-26	日清食品ホールディングス株式会社	卵白組成物及び卵白組成物の製造方法
CN121513216A (zh)	2018-03-08	2026-02-13	应用分子转运公司	用于经口递送的毒素衍生的递送构建体
WO2019173787A1 (en)	2018-03-08	2019-09-12	Applied Molecular Transport Inc.	Toxin-derived delivery constructs for oral delivery
MX2022001975A (es)	2019-08-16	2022-03-11	Applied Molecular Transport Inc	Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1366380A (en) *	1920-05-08	1921-01-25	Maurice W Grinnell	Artificial fruit and other articles and process for making the same
US3456051A (en) *	1965-10-20	1969-07-15	Takeda Chemical Industries Ltd	Soft gelatin sheet for soft gelatin capsule
IL58965A (en) *	1978-12-19	1982-08-31	Mars Inc	Production of microcapsules
EP0031812B1 (de) *	1979-03-27	1983-06-15	National Research Development Corporation	Verbesserungen an immunologischen zusammensetzungen
US4412947A (en) *	1979-09-12	1983-11-01	Seton Company	Collagen sponge
CA2071840C (en) *	1989-11-06	1997-02-04	Edith Mathiowitz	Method for producing protein microspheres
GB9116610D0 (en) *	1991-08-01	1991-09-18	Danbiosyst Uk	Preparation of microparticles
EP0625069B1 (de) *	1992-10-26	1998-12-30	Schwarz Pharma Ag	Verfahren zur herstellung von mikrokapseln
GB9420355D0 (en) *	1994-10-10	1994-11-23	Univ Nottingham	Preparation of protein microspheres, films and coatings

1994
- 1994-10-10 GB GB9420355A patent/GB9420355D0/en active Pending
1995
- 1995-10-10 WO PCT/GB1995/002393 patent/WO1996010992A1/en not_active Ceased
- 1995-10-10 PT PT95933520T patent/PT785776E/pt unknown
- 1995-10-10 DK DK95933520T patent/DK0785776T3/da active
- 1995-10-10 AU AU36148/95A patent/AU3614895A/en not_active Abandoned
- 1995-10-10 EP EP95933520A patent/EP0785776B1/de not_active Expired - Lifetime
- 1995-10-10 AT AT95933520T patent/ATE191642T1/de active
- 1995-10-10 US US08/817,025 patent/US6007791A/en not_active Expired - Lifetime
- 1995-10-10 JP JP51243896A patent/JP3990447B2/ja not_active Expired - Lifetime
- 1995-10-10 DE DE69516296T patent/DE69516296T2/de not_active Expired - Lifetime
- 1995-10-10 ES ES95933520T patent/ES2145298T3/es not_active Expired - Lifetime
1999
- 1999-12-27 US US09/473,211 patent/US6592844B2/en not_active Expired - Lifetime
2000
- 2000-04-13 GR GR20000400751T patent/GR3033210T3/el unknown

Also Published As

Publication number	Publication date
JP3990447B2 (ja)	2007-10-10
WO1996010992A1 (en)	1996-04-18
ES2145298T3 (es)	2000-07-01
DE69516296D1 (de)	2000-05-18
DE69516296T2 (de)	2000-11-23
US6007791A (en)	1999-12-28
JPH10508299A (ja)	1998-08-18
US20020182146A1 (en)	2002-12-05
EP0785776B1 (de)	2000-04-12
DK0785776T3 (da)	2000-09-18
PT785776E (pt)	2000-09-29
GR3033210T3 (en)	2000-08-31
AU3614895A (en)	1996-05-02
US6592844B2 (en)	2003-07-15
GB9420355D0 (en)	1994-11-23
EP0785776A1 (de)	1997-07-30

Legal Events

Date	Code	Title	Description
2000-09-15	UEP	Publication of translation of european patent specification

Publication	Publication Date	Title
ATE191642T1 (de)	2000-04-15	Herstellung von proteinmikrospähren, filmen und beschichtungen
NO20001765L (no)	2000-06-14	FremgangsmÕte for fremstilling av melkesyreprodukter
DE69513458D1 (de)	1999-12-30	Verfahren zur Herstellung von hochmolekularen Milchsäure-Copolyestern
DE69532858D1 (de)	2004-05-13	Verfahren zur stabilisierung von gelatine-produkten
DE69121605D1 (de)	1996-10-02	Säure-stabilisiertes Calciumcarbonat, Verfahren zu seiner Herstellung und Anwendungsmethode in der Herstellung von Säure-Papier
DE59607548D1 (de)	2001-09-27	Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
DE69428165D1 (de)	2001-10-11	Teilhydrolysat aus Milcheiweiss und Verfahren zu dessen Herstellung
ATE290405T1 (de)	2005-03-15	Verfahren zur herstellung von diagnostica
ATE195631T1 (de)	2000-09-15	Verfahren zur herstellung von milch und eine genusssäure enthalden gekühlten getränkeprodukten
DE59006185D1 (de)	1994-07-28	Herstellung kugelförmiger Dispersionen durch Kristallisation von Emulsionen.
DE60030999D1 (de)	2006-11-09	Verfahren zur herstellung von teilchen
ATE114412T1 (de)	1994-12-15	Verwendung eines pyrodextrinhydrolysates zur herstellung einer nahrungsmittelzusammensetzung zur verbesserung der serumlipidzusammensetzung.
DE69920676D1 (de)	2004-11-04	Verfahren zur Herstellung von Amin-Umsetzungsprodukt-Teilchen
DE69007800D1 (de)	1994-05-11	Verfahren zur fermentativen Herstellung von L-Arginin.
DE69011880D1 (de)	1994-10-06	Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
DE59609824D1 (de)	2002-11-28	Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
DE69808086D1 (de)	2002-10-24	Ein verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
DE69220326D1 (de)	1997-07-17	Verfahren zur Herstellung von Trans-L-Hydroxy-Prolin
ATE207114T1 (de)	2001-11-15	Herstellung von hefeerzeugnissen aus laktose enthaltenden substraten
ATE256664T1 (de)	2004-01-15	Herstellung von (s)-decahydroisochinolin-3- carbonsäure-t-butylamid
DE69020081D1 (de)	1995-07-20	Verfahren zur Herstellung von 3,3',4,4'-Biphenyltetracarbonsäure von hoher Reinheit oder deren Dianhydrid.
DE69404454D1 (de)	1997-08-28	Verfahren zur herstellung von aminomethanphosphonsäure
DE69126563D1 (de)	1997-07-24	Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
PT78161A (de)	1984-03-01	Verfahren zur herstellung von 4-amino-6,7-dimethoxy-2-<4-(furo--2-yl)-piperazin-1-yl>-chinazolin und dessen physiologisch annehmabarer salze
DE59105110D1 (de)	1995-05-11	Verfahren zur Herstellung fliessfähiger wässriger Dispersionen von Betainen.